Endovascular treatment for cerebral venous thrombosis: a multicenter study in China

He-Tao Bian; Xia Wang; Gui-You Liu; Chen Zhou; Ran Meng; Lan Liu; Jian-Gang Duan; Feng Yan; Chuan-Hui Li; Min Li; Wen Hui; Xu-Xiang Zhang; Dong Zhao; Ya-Peng Li; Qi Fang; De-Zhi Kang; Hong-Liang Zeng; Zhi-Jian Liang; Zheng-Hao Shi; Wei Yue; Qin-Jian Sun; Gui-Sheng Chen; Jian-Long Song; Zhong-Rui Yan; Qiu-Hong Ji; Kai-Jie Wang; Lu-Sha Tong; Xiao Hu; Wen-Feng Cao; Wei Yan; Rui-Jiang Gao; Qi Li; Jian-Yi Wang; Yi Liu; Bao-Jun Wang; Xiao-Hua Wang; Sheng-Tao Yao; Ye Lang; Hai-Peng Li; Craig S. Anderson; Xun-Ming Ji

doi:10.1186/s40779-025-00605-3

Your Location：

Home >

Browse articles >

Endovascular treatment for cerebral venous thrombosis: a multicenter study in China

RESEARCH | Updated：2026-05-08

- Endovascular treatment for cerebral venous thrombosis: a multicenter study in China
- Endovascular treatment for cerebral venous thrombosis: a multicenter study in China
- Military Medical Research 2026年13卷第3期页码：345-352
- Affiliations：
  
  1.Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China
  2.The George Institute for Global Health, University of New South Wales, Sydney 2000, Australia
  3.Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing 100053, China
  4.School of Statistics, University of Minnesota at Twin Cities, Minneapolis, MN 55455, USA
  5.Department of Emergency, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
  6.Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
  7.Department of Neurology and Stroke Center, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
  8.Department of Science and Technology, West China Hospital of Sichuan University, Chengdu 610041, China
  9.Department of Ophthalmology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
  10.Department of Center for Clinical and Epidemiologic Research, Beijing Anzhen Hospital, Capital Medical University, Beijing 100013, China
  11.Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China
  12.Department of Neurology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China
  13.Department of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
  14.Department of Neurology, Ganzhou People’s Hospital, Ganzhou 341000, Jiangxi, China
  15.Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Xining 530021, China
  16.Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China
  17.Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China
  18.Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
  19.Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan 750001, China
  20.Department of Neurology, the First Affiliated Hospital of USTC, Hefei 230001, China
  21.Department of Neurology, Jining First People’s Hospital, Jining 272113, Shandong, China
  22.Department of Neurology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China
  23.Department of Neurology, Tangshan Gongren Hospital, Tangshan 063099, Hebei, China
  24.Department of Neurology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
  25.Department of Neurology, Guizhou Provincial People’s Hospital, Guiyang 550002, China
  26.Department of Neurology, Jiangxi Provincial People’s Hospital, Nanchang 330006, China
  27.Department of Neurology, the First People’s Hospital of Kashi, Kashi 84000, Xinjiang, China
  28.Department of Neurology, Inner Mongolia People’s Hospital, Hohhot 010010, China
  29.Department of Neurology, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
  30.Department of Neurology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
  31.Department of Neurology, Shanxi Provincial People’s Hospital, Taiyuan 030012, China
  32.Department of Neurology, Baotou Central Hospital Inner Mongolia, Baotou 014040, Inner Mongolia Autonomous Region, China
  33.Department of Neurology, Qujing No. 1 Hospital, Qujing 655000, Yunnan, China
  34.Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi 563099, Guizhou, China
  35.Department of Neurology, Shengli Oilfield Central Hospital, Dongying 257100, Shandong, China
  36.Department of Neurology, the First People’s Hospital of Chenzhou, Chenzhou 424300, Hunan, China
  37.Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai 200433, China
- Author bio：
  
  * Xun-Ming Ji jixm@ccmu.edu.cn
- Funds：
  
  the Beijing Institute of Brain Disorders, the National Natural Science Foundation of China(82171278);the National Health and Medical Research Council (NHMRC) of Australia(APP1195237)
- DOI：10.1186/s40779-025-00605-3
  中图分类号：
- 收稿：2024-11-17，
  
  录用：2025-03-19，
  
  网络首发：2025-04-08，
  
  纸质出版：2026-03
- Accepted：
Scan QR Code
He-Tao Bian, Xia Wang, Gui-You Liu, 等. Endovascular treatment for cerebral venous thrombosis: a multicenter study in China[J]. Military Medical Research, 2026,13(3):345-352.

He-Tao Bian, Xia Wang, Gui-You Liu, et al. Endovascular treatment for cerebral venous thrombosis: a multicenter study in China[J]. Military Medical Research, 2026, 13(3): 345-352.
He-Tao Bian, Xia Wang, Gui-You Liu, 等. Endovascular treatment for cerebral venous thrombosis: a multicenter study in China[J]. Military Medical Research, 2026,13(3):345-352. DOI： 10.1186/s40779-025-00605-3.

He-Tao Bian, Xia Wang, Gui-You Liu, et al. Endovascular treatment for cerebral venous thrombosis: a multicenter study in China[J]. Military Medical Research, 2026, 13(3): 345-352. DOI： 10.1186/s40779-025-00605-3.

摘要

Abstract

Background

Endovascular treatment (EVT) is gaining popularity for the management of severe forms of cerebral venous thrombosis (CVT)

but the evidence supporting its efficacy and safety is limited.

Methods

This multicenter study included patients with CVT admitted to 104 hospitals in 31 provinces/cities in China between January 2018 and June 2022. Propensity score weighting models were used to adjust baseline confounding variables to determine the association of EVT on the primary outcome of good functional status

defined as score 0-1 on the modified Rankin Scale after hospital discharge.

Results

Of 3063 patients identified through hospital records searches

2774 adults [age (42±15.8) years

female 50.3%

]

fulfilled eligibility criteria and agreed to be included

of whom 449 (16.2%) received EVT and 2325 (83.8%) received standard care. There was no significant difference between the EVT group and the standard care group in terms of the possibility of good functional recovery [weighted risk ratio = 1.00

95% confidence interval (CI)0.96-1.03

]

. Similarly

there was no d

ifference in the likelihood of death at hospital discharge (weighted risk ratio = 1.91

95% CI 0.91-3.68). In subgroup analysis

the possibility of good functional recovery was lower in patients with intracerebral hemorrhage (weighted risk ratio = 0.88

95% CI 0.79-0.98;

for interaction = 0.01) and seizures(weighted risk ratio = 0.86

95% CI 0.76-0.95;

for interaction = 0.03).

Conclusion

In this large nationwide study

EVT was not associated with improved functional outcomes compared to standard care in patients with CVT.

关键词

Keywords

references

Ropper AH , Klein JP . Cerebral venous thrombosis . N Engl J Med . 2021 ; 385 ( 1 ): 59 - 64 .

Silvis SM , de Sousa DA , Ferro JM , Coutinho JM . Cerebral venous thrombosis . Nat Rev Neurol . 2017 ; 13 ( 9 ): 555 - 65 .

Algahtani H , Bazaid A , Shirah B , Bouges RN . Cerebral venous sinus thrombosis in pregnancy and puerperium: a comprehensive review . Brain Circ . 2022 ; 8 ( 4 ): 180 - 7 .

Ferro JM , Bousser MG , Canhao P , Coutinho JM , Crassard I , Dentali F , et al . European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European academy of neurology . Eur J Neurol . 2017 ; 24 ( 10 ): 1203 - 13 .

Ferro JM , Canhao P , Stam J , Bousser MG , Barinagarrementeria F . Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT) . Stroke . 2004 ; 35 ( 3 ): 664 - 70 .

Siddiqui FM , Dandapat S , Banerjee C , Zuurbier SM , Johnson M , Stam J , et al . Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases . Stroke . 2015 ; 46 ( 5 ): 1263 - 8 .

Ilyas A , Chen CJ , Raper DM , Ding D , Buell T , Mastorakos P , et al . Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review . J Neurointerv Surg . 2017 ; 9 ( 11 ): 1086 - 92 .

Coutinho JM , Zuurbier SM , Bousser MG , Ji X , Canhão P , Roos YB , et al . Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial . JAMA Neurol . 2020 ; 77 ( 8 ): 966 - 73 .

Vandenbroucke JP , von Elm E , Altman DG , Gøtzsche PC , Mulrow CD , Pocock SJ , et al . Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration . PLoS Med . 2007 ; 4 ( 10 ): e297 .

Bian H , Wang X , Liu L , Yan F , Lu S , Hui W , et al . Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): rationale and design . Brain Behav . 2024 ; 14 ( 4 ): e3353 .

Yaghi S , Shu L , Bakradze E , Omran SS , Giles JA , Amar JY , et al . Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study . Stroke . 2022 ; 53 ( 3 ): 728 - 38 .

Tu WJ , Yan F , Chao BH , Ji XM , Wang L . Stroke-unit care for stroke patients in China: the results from bigdata observatory platform for stroke of China . J Neurol . 2021 ; 268 ( 11 ): 4213 - 20 .

Muanda FT , Weir MA , Bathini L , Blake PG , Chauvin K , Dixon SN , et al . Association of baclofen with encephalopathy in patients with chronic kidney disease . JAMA . 2019 ; 322 ( 20 ): 1987 - 95 .

Andersen TH , Hansen K , Truelsen T , Cronqvist M , Stavngaard T , Cortsen ME , et al . Endovascular treatment for cerebral venous sinus thrombosis-a single center study . Br J Neurosurg . 2021 ; 35 ( 3 ): 259 - 65 .

Stam J , Majoie CB , van Delden OM , van Lienden KP , Reekers JA . Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study . Stroke . 2008 ; 39 ( 5 ): 1487 - 90 .

Styczen H , Tsogkas I , Liman J , Maus V , Psychogios MN . Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a single-center experience . World Neurosurg . 2019 ; 127 : e1097 - 103 .

Siddiqui FM , Weber MW , Dandapat S , Scaife S , Buhnerkempe M , Ortega-Gutierrez S , et al . Endovascular thrombolysis or thrombectomy for cerebral venous thrombosis: study of nationwide inpatient sample 2004–2014 . J Stroke Cerebrovasc Dis . 2019 ; 28 ( 6 ): 1440 - 7 .

Saposnik G , Bushnell C , Coutinho JM , Field TS , Furie KL , Galadanci N , et al . Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American heart association . Stroke . 2024 ; 55 ( 3 ): e77 - 90 .

Goyal M , Fladt J , Coutinho JM , McDonough R , Ospel J . Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities . J Neurointerv Surg . 2022 ; 14 ( 8 ): 788 - 93 .

Lindgren E , Silvis SM , Hiltunen S , Heldner MR , Serrano F , de Scisco M , et al . Acute symptomatic seizures in cerebral venous thrombosis . Neurology . 2020 ; 95 ( 12 ): e1706 - 15 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

暂无数据